The role of the public and of public participation in science-based policy decisions has been and still represents a controversial issue. In science policy, a great deal of discussion surrounds the question of whether and how the general public or some selected publics should be involved in decisions related to technoscience innovation. This controversy is inherent in the history of science policy  but has become more vigorous due to emergencies in the health ﬁeld (especially in Europe). Divergent opinions about this role are based on different visions of the relationships between science and society and, more speciﬁcally, of science in democratic societies.
|Number of pages||3|
|Publication status||Published - 2007|
- clinical trials
- public participation
- risk assessment